⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAPR News
Capricor Therapeutics Inc
Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Investors to Inquire about Securities Investigation
accessnewswire.com
CAPR
Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)
accessnewswire.com
CAPR
Capricor Investor News: If You Have Suffered Losses in Capricor Therapeutics Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com
CAPR
CAPR SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. for Possible Securities Law Violations
accessnewswire.com
CAPR
Capricor Therapeutics ($CAPR) Investors Are Notified of The Ongoing Securities Fraud Investigation After Clinical Data Issues Lead to 64% Stock Drop
accessnewswire.com
CAPR
CAPR Investor Alert: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. (CAPR) for Potential Securities Fraud
accessnewswire.com
CAPR
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
businesswire.com
CAPR
$CAPR Stock Loss: Capricor Therapeutics May Have Misrepresented its Clinical Data to Investors - Contact BFA Law About its Pending Securities Fraud Investigation
accessnewswire.com
CAPR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - CAPR
accessnewswire.com
CAPR
Shareholder Alert - Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action Lawsuit
businesswire.com
CAPR